Pinsent Masons advises Yule Catto on the sale of Uquifa

01 Dec 2011 | 10:49 am | 1 min. read

International law firm Pinsent Masons has advised Yule Catto & Co plc, international producer of speciality chemicals, on the sale of its pharmaceuticals business, Uquifa to the listed Indian chemicals manufacturer Vivimed Labs for £35m.

Uquifa, which operates through Spanish and Mexican subsidiaries, is an established manufacturer of active pharmaceutical ingredients. The company has manufacturing sites in Spain and Mexico employing a total of 390 people. 

Adrian Whitfield, Chief Executive of Yule Catto said: "I am delighted to be able to announce this disposal.  Following the PolymerLatex acquisition we completed earlier this year, this marks the final step in a long process of transforming Yule Catto into a substantial highly focussed Specialty Polymer business.  We are pleased we have been able to find a good home for our Pharma business and wish the new owners and our former employees every success." 

The Pinsent Masons team advising on the sale was led by Martin Shaw, Head of Corporate, Europe, and Shiv Sibal, Senior Associate, supported by Emma Metcalfe (corporate), Michael Hunter and Jon Robinson (tax).  The team also worked closely with Yule Catto's Spanish advisers, Garrigues, and their Mexican advisers, Baker & McKenzie. Vivimed were advised by Dickinson Dees. 

Shiv Sibal, Corporate Senior Associate at Pinsent Masons LLP, commented: "The sale of Uquifa represents an important development for Yule Catto and will allow them to continue to focus on the growth of their Polymers division following their transformational acquisition of PolymerLatex earlier this year.  Having worked closely with them on the PolymerLatex acquisition, we are delighted to have supported Yule Catto again in achieving one of its strategic objectives."

Latest press releases

Show me all press releases

Pinsent Masons appointed to AIG’s UK and EMEA Corporate legal panels

Multinational law firm Pinsent Masons has been appointed to insurance giant AIG’s UK and EMEA Corporate legal panels with a broad remit to provide advice on a full range of legal services.

Pinsent Masons appoints fourth partner in Amsterdam with life sciences patent specialist

Multinational law firm Pinsent Masons has recruited partner András Kupecz to its European life sciences team, further bolstering its Netherlands-based technology, science and industry capabilities.

Pinsent Masons advises Photon Energy N.V. and Bankhaus Scheich Wertpapierspezialist AG on EUR 55m GREEN bonds

Multinational law firm Pinsent Masons has advised Photon Energy N.V. and Bankhaus Scheich Wertpapierspezialist AG on the issuance of EUR 55m 6.50% GREEN bonds due 2027.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Photon Energy N.V. and Bankhaus Scheich Wertpapierspezialist AG on EUR 55m GREEN bonds

Multinational law firm Pinsent Masons has advised Photon Energy N.V. and Bankhaus Scheich Wertpapierspezialist AG on the issuance of EUR 55m 6.50% GREEN bonds due 2027.

Pinsent Masons appoints Head of Corporate, Asia Pacific

Multinational law firm Pinsent Masons has appointed Singapore-based partner, Nicholas Hanna, as its new Head of Corporate, APAC.

Pinsent Masons advises Zimmer MedizinSysteme GmbH on the acquisition of Enraf-Nonius B.V.

Multinational law firm Pinsent Masons has advised Zimmer MedizinSysteme GmbH on the acquisition of Enraf-Nonius B.V., including interests in France and Thailand, from managing directors Len De Jong and Tom Doodkorte.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts